A Multicentre Observational Study to Assess Long-term Outcome of Participants in the EXCELLENT Clinical Trial
Recruiting
Observational Study
Acute Myocardial Infarction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 48 (estimated)
- Sponsor
- CellProthera · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The PERFECT study is an observational study designed to follow patients randomised in the EXCELLENT study (NCT02669810) for 10 years. The aim is to assess the long-term clinical outcomes for patients randomised to the Standard of Care arm or the ProtheraCytes arm.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria :
* Completion of the last visit in the EXCELLENT interventional clinical trial.
* Participation must be within 10 years after the randomization in the EXCELLENT trial
Exclusion criteria :
* Patients randomized to the ProtheraCytes® group who did not receive the product of the …
Contacts